$AMAT

Nalamasu Omkaram sold $20.8M of AMAT

Nalamasu Omkaram (Senior Vice President, CTO) sold 35,000 shares of APPLIED MATERIALS INC /DE (AMAT) at an average of $592.98 ($590.20–$596.52, $20.75M total) across 9 trades over 2026-06-15 to 2026-06-16.

Original reporting
SEC EDGAR · Nalamasu Omkaram
Published Jun 17, 2026, 10:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 10:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMAT
Neutral
medium confidence
Mentioned
$AMAT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMATNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale size (~35,000 shares; ~$20.75M) and that it was not under a pre-arranged 10b5-1 plan, which can influence short-term sentiment.

02

Market read

Traders may watch for sentiment drift or follow-on selling, but the filing lacks any new guidance, contract, or operational catalyst.

03

What to watch

No context on total compensation, prior sale history, or whether proceeds fund planned purchases; without that, the signal-to-noise for price impact is low.

Relevance 7/10Novelty 5/10Timing: Filed June 17; trades occurred June 15–16.

Background

This is an SEC Form 4 insider transaction disclosure for Applied Materials (AMAT) by Nalamasu Omkaram, SVP and CTO.

Company-level read

Ticker impact

$AMATNeutralMedium confidence
Context

Applied Materials disclosed an insider open-market sale by its SVP/CTO of 35,000 shares for about $20.75M across 9 trades (no 10b5-1).

Expected impact

Near-term: slight negative bias; medium-term: likely limited follow-through absent other catalysts.

Evidence & confidence

The filing is primary-source and sizable, but insider sales are often diversified and the disclosure provides no new operational or guidance information.

Market effects

Could marginally affect semiconductor equipment sentiment via insider-signal optics, but no sector-wide datapoint is provided.

No explicit regional linkage beyond US-listed issuer disclosure.

No global supply/demand or regulatory development mentioned.

Counterpoint

The sale may be routine diversification or tax-related; absence of a 10b5-1 plan does not necessarily imply bearish fundamentals.

Key entities

  • Applied Materials Inc /DE

    Subject of the Form 4 insider sale disclosure.

  • Nalamasu Omkaram

    SVP and CTO who sold 35,000 shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BACMed

US Futures Hold Steady Ahead of Inflation Report

US stock futures were stable on Wednesday ahead of the September inflation report. Bank of America shares fell over 2% after $1.2B in penalties from regulators. Memory stocks declined due to AI investment concerns and Chinese competition, with Micron down 4.6%. Financial stocks also dropped post-earnings, including Citigroup (-5.3%) and Wells Fargo (-2.6%).

$AMATMed

Applied Materials Targets AI-Led Market Share Gains and Higher Margins by 2030

Applied Materials (AMAT) expects to gain market share in wafer-fab equipment, leading-edge logic, DRAM, and advanced packaging by 2030. The company anticipates revenue growth in process control and services, with AIx platform improving yield and factory output. Financial targets include $12B+ in services revenue and 54% gross margin by 2030. AMAT plans to return 80-100% of free cash flow to shareholders.

$AMATHighAI 8/10

Why Applied Materials Sank Today

Applied Materials (AMAT) shares fell 7.2% after an investor presentation lacked revenue growth projections. The company forecast 2030 margins of 54% gross and 40% operating, with services revenue exceeding $12B. Investors reacted negatively to the absence of overall revenue guidance, despite bullish long-term outlooks on AI-driven growth.

$JPMHighAI 8/10

Wall Street Lunch: Bank Earnings Nothing To Write Home About (undefined:JPM)

JPMorgan Chase (JPM) missed Q3 earnings estimates, with Fixed Income & Markets revenue falling 4% Y/Y. Goldman Sachs (GS) beat estimates, while Wells Fargo (WFC) and Citigroup (C) showed mixed results. UnitedHealth Group (UNH) raised its full-year outlook, and Johnson & Johnson (JNJ) reported a Q3 beat but saw shares weighed down by MedTech revenue. Applied Materials (AMAT) declined post-investor presentation. Fund managers increased tech sector exposure to a six-year high.